The application of ctDNA technology for early Cancer diagnostics in Samoa
Bibliographic record
Abstract
Abstract Fragmented pieces of tumor DNA can be found in the human blood circulation. These tumor DNA fragments can be isolated and quantified to produce detailed information related to cancer progression and treatment responses in patients. This monitoring and analysis comprises a novel cancer detection method known as circulating tumor DNA (ctDNA). Given that gaining access to and obtaining biopsy samples from solid cancers in people is not always possible or as straightforward as needed, the utilization of a simple blood sample to allow detection and monitoring of cancer growth and behavior is highly desirable. This simple detection and monitoring technology is likely enhance the precision of cancer care for patients, and support early cancer detection. The purpose of this work was to explore in detail the potential for ctDNA to be utilized as an early cancer detection tool within the healthcare setting within the Pacific in Samoa. Consultation was sought with senior Government officials, Medical, Nursing, Health and Community research staff concerning the development and implementation of ctDNA as a diagnostic tool within the clinical health care setting throughout Samoa. The application of the ctDNA technology as an early cancer detection tool within the clinical healthcare setting was explored in depth and received with approval, given issues that currently exist concerning resource constraints and late cancer presentations. It is anticipated that the utility of ctDNA as an early cancer detection tool will support improved cancer management within the health care setting in Samoa.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.001 | 0.002 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.001 | 0.001 |
| Science and technology studies | 0.001 | 0.001 |
| Scholarly communication | 0.001 | 0.000 |
| Open science | 0.000 | 0.001 |
| Research integrity | 0.001 | 0.000 |
| Insufficient payload (model declined to judge) | 0.002 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".